A synthetic platform for developing recombinant adeno-associated virus type 8 producer cell lines

Keyphrases

• Recombinant Adeno-associated Virus (rAAV) 100%
• AAV8 100%
• Producer Cell Line 100%
• Synthetic Platform 100%
• Gene Therapy 20%
• Capsid 20%
• Clinical Application 20%
• Coding Sequence 20%
• High Dose 20%
• Protein Production 20%
• Gene Delivery 20%
• Synthetic Biology 20%
• Tropism 20%
• Viral Vectors 20%
• HEK293 20%
• Titer 20%
• Large-scale Production 20%
• Multiple Tissues 20%
• Capsid Formation 20%
• Capping Protein 20%
• Induction Conditions 20%
• AAV Serotypes 20%
• Particle Content 20%
• AAV2 20%
• Stable Production 20%
• Plasmid Transfection 20%
• E4orf6 20%
• Cell Line Development 20%
• Genetic Modules 20%
• Development Platform 20%
• Cap Gene 20%
• Line Construction 20%
• Packaging Module 20%

Biochemistry, Genetics and Molecular Biology

• Capsid 100%
• Transfection 100%
• Adeno Associated Virus 100%
• Serotype 100%
• Adeno Associated Virus 8 100%
• Genetics 50%
• Gene Therapy 50%
• Titer 50%
• Plasmid 50%
• Gene Targeting 50%
• Drug Megadose 50%
• Intron 50%
• Virus Vector 50%
• Large Scale Production 50%

Immunology and Microbiology

• Cell Line 100%
• Adeno Associated Virus 8 100%
• Capsid 33%
• Serotype 33%
• Genetic Transfection 33%
• Adeno Associated Virus 33%
• Intron 16%
• Viral Vector 16%
• Adeno-Associated Virus 16%
• Titer 16%
• Plasmid 16%
• Drug Megadose 16%
• Large Scale Production 16%
• Gene Targeting 16%
• Replication 16%